Earnings4527ROHTO PHARMACEUTICAL CO.,LTD.
Rohto Pharmaceutical Reports Q1 FY2027 Earnings Presentation: Revenue of 91.6 billion
TOKYO, Aug 06 (Pulse News Wire) – ROHTO PHARMACEUTICAL CO.,LTD. (4527.T) released its earnings presentation for Q1 FY2027.
Revenue was ¥91.6 billion. Ordinary profit was ¥14.5 billion. Net profit was ¥10.6 billion.
Total assets stood at ¥490 billion.
Financial results — FY2027/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥91,624M | +11.8% |
| Operating profit | ¥13,663M | +16.8% |
| Net profit | ¥10,650M | -9.5% |
Next period forecast
Revenue
¥372,300M
+8.3%Op. profit
¥45,000M
+9.4%Net profit
¥35,200M
+2.8%Figures in millions of yen
End of article